Although inhibitors of VEGF/VEGFR signaling were expected to inhibit tumor growth via inhibition of endothelial cell proliferation, experimental evidence and clinical observations indicate that it induces actual vascular regression, most likely by inhibiting pro-survival VEGF functions [8,9]. The gene discussed is KDR; the disease is neoplasm.